LONG TRACKING ANALYSIS ABOUT MANAGEMENT OF AZACITIDINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME

被引：0
|
作者：
Molero, A. [1 ]
Mora, E. [2 ,3 ]
Avila, F. [4 ]
Revelles, M. [5 ]
Merchan, B. [1 ]
Regadera, A. [2 ,3 ]
Alonso, S. [4 ]
Montoro, J. [1 ]
Martin, M. [2 ,3 ]
Benlloch, L. [6 ]
Garcia, R. [5 ]
Bernal, T. [4 ]
Sanz, G. [2 ,3 ]
Valcarcel, D. [1 ]
机构：
[1] Hosp Univ Vall dHebron, Hematol, Barcelona, Spain
[2] Hosp Univ La Fe, Hematol, Valencia, Spain
[3] Politecn La Fe, Hematol, Valencia, Spain
[4] Hosp Univ Cent Asturias Oviedo, Hematol, Oviedo, Spain
[5] Hosp Univ Virgen de la Victoria, Hematol, Malaga, Spain
[6] Spanish MDS Grp, Valencia, Spain
来源：
LEUKEMIA RESEARCH | 2017年 / 55卷
关键词：
D O I：
10.1016/S0145-2126(17)30219-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
106
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [41] Clinical Experience with Azacitidine In Secondary Myelodysplastic Syndrome In Spain
    Garcia, Regina
    Sanz, Guillermo F.
    de Miguel Llorente, Dunia
    Nomdedeu, Benet
    Mar Romero, Ma
    Bernal, Teresa
    Besalduch, Juan
    Amutio, Elena
    Brunet, Salut
    BLOOD, 2010, 116 (21) : 772 - 772
  • [42] DETERMINATION OF PERIPHERAL BLOOD CYTOKINES AND BONE MARROW FLOW CYTOMETRY ANALYSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME TREATED WITH AZACITIDINE
    Buquicchio, F.
    Ciuffreda, L.
    Santoro, M.
    Patruno, T.
    Porro, N.
    Tito, M.
    Rocchitelli, A.
    Tarantini, G.
    Desantis, G.
    Diomede, D.
    Santorsola, D.
    Riezzo, A.
    HAEMATOLOGICA, 2008, 93 : S47 - S47
  • [43] INFECTIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA TREATED WITH AZACITIDINE: RETROSPECTIVE ANALYSIS FROM A SINGLE CENTER
    Binotto, G.
    Quinto, A. M.
    De March, E.
    Lessi, F.
    Castelli, M.
    Nabergoj, M.
    Gianesello, I.
    Pavanello, F.
    Branca, A.
    Zambello, R.
    Adami, F.
    Semenzato, G.
    LEUKEMIA RESEARCH, 2015, 39 : S47 - S47
  • [44] Treatment of myelodysplastic syndrome: Questions raised by the azacitidine experience
    Kantarjian, HM
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2415 - 2416
  • [45] Treatment of Advanced Myelodysplastic Syndrome With Demethylating Agents: Azacitidine
    Ades, Lionel
    Itzykson, Raphael
    Fenaux, Pierre
    SEMINARS IN HEMATOLOGY, 2012, 49 (04) : 323 - 329
  • [46] Eosinophilic Pneumonia Associated With Azacitidine in a Patient With Myelodysplastic Syndrome
    Nair, Girish B.
    Charles, Melissa
    Ogden, Lorna
    Spiegler, Peter
    RESPIRATORY CARE, 2012, 57 (04) : 631 - 633
  • [47] Approval summary: Azacitidine for treatment of myelodysplastic syndrome subtypes
    Kaminskas, E
    Farrell, A
    Abraham, S
    Baird, A
    Hsieh, LS
    Lee, SL
    Leighton, JK
    Patel, H
    Rahman, A
    Sridhara, R
    Wang, YC
    Pazdur, R
    CLINICAL CANCER RESEARCH, 2005, 11 (10) : 3604 - 3608
  • [48] Azacitidine: A Review of its Use in the Management of Myelodysplastic Syndromes
    Lammers, Philip E.
    Cashen, Amanda F.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1189 - 1197
  • [49] A Phase II Study of Nivolumab or Ipilimumab with or without Azacitidine for Patients with Myelodysplastic Syndrome (MDS)
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Montalban-Bravo, Guillermo
    Daver, Naval G.
    Jabbour, Elias J.
    Alvarado, Yesid
    DiNardo, Courtney D.
    Ravandi, Farhad
    Borthakur, Gautam
    Bose, Prithviraj
    Pemmaraju, Naveen
    Naqvi, Kiran
    Cortes, Jorge E.
    Kadia, Tapan M.
    Konopleva, Marina Y.
    Colla, Simona
    Yang, Hui
    Rausch, Caitlin R.
    Gasior, Yvonne
    Bueso-Ramos, Carlos E.
    Kanagal-Shamanna, Rashmi
    Patel, Keyur P.
    Kantarjian, Hagop M.
    BLOOD, 2018, 132
  • [50] DNA Methylation Changes Following 5-azacitidine Treatment in Patients with Myelodysplastic Syndrome
    Huong Thi Thanh Tran
    Kim, Hee Nam
    Lee, Il-Kwon
    Kim, Yeo-Kyeoung
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (02) : 207 - 213
12345